CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO

Introducing Etizolam-D3, the latest benzodiazepine internal standard from Cerilliant.

Etizolam-D3, 1 mL, 100 ug/mL E-082
100 µg/mL in Methanol

An internal standard suitable for quantitation of etizolam levels in urine or other matrices by LC/MS or GC/MS in forensic analysis, clinical toxicology, or urine drug testing applications. Etizolam, sold under brand names such as Etilaam, Etizola, or Depas, is a benzodiazepine analog used for the short-term treatment of insomnia, anxiety, or panic attacks. Etizolam is also sold on the designer drug market with cases of abuse noted in Europe and the US.

Coming soon, Cerilliant will introduce the following benzodiazepine internal standards:
P-093 Phenazepam-D4
N-088 Norchlordiazepoxide-D5

Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO 17034 and ISO/IEC 17025 & certified ISO 9001.

All New Product Announcements

© 2021 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
MilliporeSigma is a business of Merck KGaA, Darmstadt, Germany
Products | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact